Mary Elizabeth Lynch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mary Elizabeth Lynch has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
Alexander J. Clark
4 shared publicationsJana Sawynok
3 shared publications- Jana Sawynok
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
3 shared publications Alexander John Clark
2 shared publicationsBenedikt Fischer
2 shared publicationsCaitlin Sinclair
Dalhousie University , Fort MacMurray, Alberta , Canada
2 shared publications
Latest Publications
- Open Access
- 17 June 2024
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 8 (1) , 2346253
Mission Critical, a Call to Action for Implementation of the Recommendations of the Canadian Pain Task Force
- 17 June 2024
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 8 (1) , 2346253
Open AccessMission Critical, a Call to Action for Implementation of the Recommendations of the Canadian Pain Task Force
- Open Access
- 17 May 2023
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 21 (10) , 2022-2081
Exploring current nutritional programming and resources available to people living with HIV or AIDS in Canada: a scoping review
Objective: The objective of this scoping review is to map the current literature and resources available on nutrition and food programming for people living with HIV and AIDS in Canada. This review is phase 1 of a 4-phase project, called FoodNOW (Food to eNhance Our Wellness), a community-based nutritional needs assessment of people living with HIV or AIDS living in Nova Scotia, Canada. Introduction: People living with HIV or AIDS may experience nutritional challenges, including nutritional deficiencies associated with the virus, food insecurity, and nutrition-drug interactions. Nutritional programming is often required for optimal care for people living with HIV or AIDS. The literature, however, has not been sufficiently mapped to create a comprehensive picture of available programming. This review has informed the development of subsequent study phases, and will contribute towards shaping and planning food programs, as well as evaluating the need for subsequent systematic reviews. Inclusion criteria: This review has considered literature focused on nutrition and food programming and resources in Canada for people living with HIV or AIDS. People living with HIV or AIDS of any age, sex, race, gender identity, or sexual orientation, as well as pregnant and lactating people, have been included as the population of interest. Methods: The databases searched were MEDLINE (Ovid), CINAHL (EBSCO), Academic Search Premier (EBSCO), Social Services Abstracts (ProQuest), and Scopus. Sources of gray literature searched included government and organization websites, and Google searches. The database search was conducted in July 2021 and the gray literature searches were conducted in August and October 2021. Searches were limited to evidence published or translated in English. Two independent reviewers conducted title and abstract screening, and potentially relevant results were retrieved in full. Full-text screening and data extraction was conducted by 2 independent reviewers using a data extraction tool designed specifically for the scoping review objectives and research inclusion criteria, and any conflicts were resolved through discussion. Results are presented in both tabular and diagrammatic formats, with a narrative summary. Results: A total of 581 results were screened (published and gray literature). A total of 64 results were included in the review. The 6 reasons for exclusion at full-text review were: i) not nutrition and food programming (n= 83); ii) not Canadian (n= 37); iii) duplicates (n= 22); iv) not focused on people living with HIV or AIDS (n= 6); v) conference abstract (n= 1); and vi) not in English (n= 1). A total of 76 resources were located, as some of the 64 results included offered more than one resource. We have organized the 76 resources into 6 categories: i) charitable food provision (n = 21/76; 27.6%); ii) financial aid (n = 14/76; 18.4%); iii) nutrition care (n =12/76; 15.8%); iv) providing access to secondary sources (n= 10/76; 13.2%); v) food and nutrition expertise (n= 10/76; 13.2%); and vi) population health promotion (n= 9/76; 11.8%). Recommendations for future research and programming are discussed. Conclusions: This scoping review demonstrates that current programming relies heavily on charitable food provision services for people living with HIV and AIDS and that there is an unequal distribution of resources across Canada. Program expansion to target diverse populations with more equal distribution across Canada may improve overall health outcomes for people living with HIV and AIDS. Future research is needed to evaluate the effectiveness of available programming and the needs of end-users (people living with HIV and AIDS and their supports). FoodNOW will build on these findings to further explore and address the needs of people living with HIV and AIDS. Details of the systematic review are available at: Open Science Framework https://osf.io/97x3r
- 17 May 2023
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 21 (10) , 2022-2081
Open AccessExploring current nutritional programming and resources available to people living with HIV or AIDS in Canada: a scoping review
Objective: The objective of this scoping review is to map the current literature and resources available on nutrition and food programming for people living with HIV and AIDS in Canada. This review is phase 1 of a 4-phase project, called FoodNOW (Food to eNhance Our Wellness), a community-based nutritional needs assessment of people living with HIV or AIDS living in Nova Scotia, Canada. Introduction: People living with HIV or AIDS may experience nutritional challenges, including nutritional deficiencies associated with the virus, food insecurity, and nutrition-drug interactions. Nutritional programming is often required for optimal care for people living with HIV or AIDS. The literature, however, has not been sufficiently mapped to create a comprehensive picture of available programming. This review has informed the development of subsequent study phases, and will contribute towards shaping and planning food programs, as well as evaluating the need for subsequent systematic reviews. Inclusion criteria: This review has considered literature focused on nutrition and food programming and resources in Canada for people living with HIV or AIDS. People living with HIV or AIDS of any age, sex, race, gender identity, or sexual orientation, as well as pregnant and lactating people, have been included as the population of interest. Methods: The databases searched were MEDLINE (Ovid), CINAHL (EBSCO), Academic Search Premier (EBSCO), Social Services Abstracts (ProQuest), and Scopus. Sources of gray literature searched included government and organization websites, and Google searches. The database search was conducted in July 2021 and the gray literature searches were conducted in August and October 2021. Searches were limited to evidence published or translated in English. Two independent reviewers conducted title and abstract screening, and potentially relevant results were retrieved in full. Full-text screening and data extraction was conducted by 2 independent reviewers using a data extraction tool designed specifically for the scoping review objectives and research inclusion criteria, and any conflicts were resolved through discussion. Results are presented in both tabular and diagrammatic formats, with a narrative summary. Results: A total of 581 results were screened (published and gray literature). A total of 64 results were included in the review. The 6 reasons for exclusion at full-text review were: i) not nutrition and food programming (n= 83); ii) not Canadian (n= 37); iii) duplicates (n= 22); iv) not focused on people living with HIV or AIDS (n= 6); v) conference abstract (n= 1); and vi) not in English (n= 1). A total of 76 resources were located, as some of the 64 results included offered more than one resource. We have organized the 76 resources into 6 categories: i) charitable food provision (n = 21/76; 27.6%); ii) financial aid (n = 14/76; 18.4%); iii) nutrition care (n =12/76; 15.8%); iv) providing access to secondary sources (n= 10/76; 13.2%); v) food and nutrition expertise (n= 10/76; 13.2%); and vi) population health promotion (n= 9/76; 11.8%). Recommendations for future research and programming are discussed. Conclusions: This scoping review demonstrates that current programming relies heavily on charitable food provision services for people living with HIV and AIDS and that there is an unequal distribution of resources across Canada. Program expansion to target diverse populations with more equal distribution across Canada may improve overall health outcomes for people living with HIV and AIDS. Future research is needed to evaluate the effectiveness of available programming and the needs of end-users (people living with HIV and AIDS and their supports). FoodNOW will build on these findings to further explore and address the needs of people living with HIV and AIDS. Details of the systematic review are available at: Open Science Framework https://osf.io/97x3r
- Open Access
- 17 June 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-14
Observational Study of Qigong as a Complementary Self-Care Practice at a Tertiary-Care Pain Management Unit
Qigong, which can be characterized in many different ways, is offered as a complementary self-care practice at a tertiary-care pain management unit in Halifax, Nova Scotia. This report provides a quantitative and qualitative assessment of two groups engaged in qigong practice in this context as part of two Research in Medicine (RIM) projects (2014-15, 2016-17). It includes assessments of pain, mood, quality of life, sleep, and fatigue, considers outcomes in relation to the amount of practice, and considers whether health attitudes would help determine who might benefit from the practice. There were 43 participants (28 ongoing practitioners, 15 new to qigong). The ongoing practice group in RIM2 had significant benefits over time in pain, mood, quality of life, and fatigue in quantitative scores, but changes were not significant in RIM 1. There were no differences in any measures in those new to qigong. Qualitative comments in core and other domains reflected good or better outcomes in 16 subjects in the ongoing group who practiced consistently. In those who practiced less, results were more variable. In most of those new to qigong, the practice was limited and comments indicate minimal changes. Those engaged in qigong have a stronger internal health locus of control than control subjects. Diligent qigong practice provides multiple health benefits for those with chronic pain, and qualitative assessments are essential for documenting these effects. For those new to qigong, factors needed to effectively engage practice need to be explored further to optimize program delivery. The trial is registered with http://www.clinicaltrials.gov (NCT04279639).
- 17 June 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-14
Open AccessObservational Study of Qigong as a Complementary Self-Care Practice at a Tertiary-Care Pain Management Unit
Qigong, which can be characterized in many different ways, is offered as a complementary self-care practice at a tertiary-care pain management unit in Halifax, Nova Scotia. This report provides a quantitative and qualitative assessment of two groups engaged in qigong practice in this context as part of two Research in Medicine (RIM) projects (2014-15, 2016-17). It includes assessments of pain, mood, quality of life, sleep, and fatigue, considers outcomes in relation to the amount of practice, and considers whether health attitudes would help determine who might benefit from the practice. There were 43 participants (28 ongoing practitioners, 15 new to qigong). The ongoing practice group in RIM2 had significant benefits over time in pain, mood, quality of life, and fatigue in quantitative scores, but changes were not significant in RIM 1. There were no differences in any measures in those new to qigong. Qualitative comments in core and other domains reflected good or better outcomes in 16 subjects in the ongoing group who practiced consistently. In those who practiced less, results were more variable. In most of those new to qigong, the practice was limited and comments indicate minimal changes. Those engaged in qigong have a stronger internal health locus of control than control subjects. Diligent qigong practice provides multiple health benefits for those with chronic pain, and qualitative assessments are essential for documenting these effects. For those new to qigong, factors needed to effectively engage practice need to be explored further to optimize program delivery. The trial is registered with http://www.clinicaltrials.gov (NCT04279639).
- Open Access
- 22 April 2021
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 5 (2) , A3-A33
Symposia Abstracts
Symposium Chair: Sitara de Gagne, Patient Partner, Toronto, Ontario, Canada, sitaradegagne@hotmail.com
- 22 April 2021
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 5 (2) , A3-A33
Open AccessSymposia Abstracts
Symposium Chair: Sitara de Gagne, Patient Partner, Toronto, Ontario, Canada, sitaradegagne@hotmail.com
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 4 (1) , 204-209
COVID-19 impact and response by Canadian pain clinics: A national survey of adult pain clinics
As the result of public health authority responses to the COVID-19 pandemic, pain clinics have had to cease providing in-person appointments to reduce contact between patients and staff. Over the p...
- 1 January 2020
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 4 (1) , 204-209
Open AccessCOVID-19 impact and response by Canadian pain clinics: A national survey of adult pain clinics
As the result of public health authority responses to the COVID-19 pandemic, pain clinics have had to cease providing in-person appointments to reduce contact between patients and staff. Over the p...
- Open Access
- 28 August 2019
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 3 (1) , 180-189
Methadone vs. morphine SR for treatment of neuropathic pain: A randomized controlled trial and the challenges in recruitment
Introduction: Accumulating evidence has identified a number of advantages for methadone over other opioids for the treatment of chronic pain including: agonist action at both μ and δ opioid receptors, N-methyl-D-aspartate (NMDA) antagonist activity and the ability to inhibit the re-uptake of monoamines. It was hypothesized that with these 3 mechanisms of action methadone might be a good option for the treatment of neuropathic pain. Methods: This was a double-blind, randomized, controlled trial comparing methadone to controlled release morphine. The primary objective was to determine if methadone is clinically inferior versus non-inferior to morphine as an analgesic. Results: We attempted recruitment at 3 academic pain centers over a 3-year period. In the end only 14 participants were able to be recruited, 5 withdrew and only 9 completed the trial. This study was underpowered. All participants showed a mean reduction in pain intensity according to the numeric rating scale for pain intensity (morphine 5.86 to 4.38, methadone 6.11 to 4.5) and reported pain relief as compared with pretreatment but the sample size was too small for statistical analysis. Discussion: Reasons for challenges in recruitment included tight inclusion and exclusion criteria and high participant burden. In addition, there was significant heterogeneity of patients between the three sites leading to differences in reasons for exclusion. This included seemingly disparate reasons at the different sites including few participants who were methadone naïve vs avoidance or fear of opioids. In the end, we were unable to answer the question of the study.
- 28 August 2019
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 3 (1) , 180-189
Open AccessMethadone vs. morphine SR for treatment of neuropathic pain: A randomized controlled trial and the challenges in recruitment
Introduction: Accumulating evidence has identified a number of advantages for methadone over other opioids for the treatment of chronic pain including: agonist action at both μ and δ opioid receptors, N-methyl-D-aspartate (NMDA) antagonist activity and the ability to inhibit the re-uptake of monoamines. It was hypothesized that with these 3 mechanisms of action methadone might be a good option for the treatment of neuropathic pain. Methods: This was a double-blind, randomized, controlled trial comparing methadone to controlled release morphine. The primary objective was to determine if methadone is clinically inferior versus non-inferior to morphine as an analgesic. Results: We attempted recruitment at 3 academic pain centers over a 3-year period. In the end only 14 participants were able to be recruited, 5 withdrew and only 9 completed the trial. This study was underpowered. All participants showed a mean reduction in pain intensity according to the numeric rating scale for pain intensity (morphine 5.86 to 4.38, methadone 6.11 to 4.5) and reported pain relief as compared with pretreatment but the sample size was too small for statistical analysis. Discussion: Reasons for challenges in recruitment included tight inclusion and exclusion criteria and high participant burden. In addition, there was significant heterogeneity of patients between the three sites leading to differences in reasons for exclusion. This included seemingly disparate reasons at the different sites including few participants who were methadone naïve vs avoidance or fear of opioids. In the end, we were unable to answer the question of the study.
- Open Access
Qigong and Fibromyalgia circa 2017
Qigong is an internal art practice with a long history in China. It is currently characterized as meditative movement (or as movement-based embodied contemplative practice), but is also considered as complementary and alternative exercise or mind–body therapy. There are now six controlled trials and nine other reports on the effects of qigong in fibromyalgia. Outcomes are related to amount of practice so it is important to consider this factor in overview analyses. If one considers the 4 trials (201 subjects) that involve diligent practice (30–45 min daily, 6–8 weeks), there are consistent benefits in pain, sleep, impact, and physical and mental function following the regimen, with benefits maintained at 4–6 months. Effect sizes are consistently in the large range. There are also reports of even more extensive practice of qigong for 1–3 years, even up to a decade, indicating marked benefits in other health areas beyond core domains for fibromyalgia. While the latter reports involve a limited number of subjects and represent a self-selected population, the marked health benefits that occur are noteworthy. Qigong merits further study as a complementary practice for those with fibromyalgia. Current treatment guidelines do not consider amount of practice, and usually make indeterminate recommendations.
Open AccessQigong and Fibromyalgia circa 2017
Qigong is an internal art practice with a long history in China. It is currently characterized as meditative movement (or as movement-based embodied contemplative practice), but is also considered as complementary and alternative exercise or mind–body therapy. There are now six controlled trials and nine other reports on the effects of qigong in fibromyalgia. Outcomes are related to amount of practice so it is important to consider this factor in overview analyses. If one considers the 4 trials (201 subjects) that involve diligent practice (30–45 min daily, 6–8 weeks), there are consistent benefits in pain, sleep, impact, and physical and mental function following the regimen, with benefits maintained at 4–6 months. Effect sizes are consistently in the large range. There are also reports of even more extensive practice of qigong for 1–3 years, even up to a decade, indicating marked benefits in other health areas beyond core domains for fibromyalgia. While the latter reports involve a limited number of subjects and represent a self-selected population, the marked health benefits that occur are noteworthy. Qigong merits further study as a complementary practice for those with fibromyalgia. Current treatment guidelines do not consider amount of practice, and usually make indeterminate recommendations.
- Open Access
- 1 January 2017
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 1 (1) , 2-7
“One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain
- 1 January 2017
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 1 (1) , 2-7
Open Access“One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain
- Open Access
- 1 January 2017
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 1 (1) , A60-A167
Research Poster Abstracts
- 1 January 2017
- Published by Taylor & Francis in Canadian Journal of Pain
- Vol. 1 (1) , A60-A167
Open AccessResearch Poster Abstracts
- 13 November 2015
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 27 (3) , 189-191
Cannabinoids in the management of chronic pain: a front line clinical perspective
Chronic pain is an escalating public health problem. Currently available treatments are inadequate to control chronic pain conditions, and there is a critical need for novel treatments. Over a half century of elegant preclinical research has identified the presence of a sophisticated endocannabinoid system that is part of our natural pain and immune defense network. Convergent work has supported the significant potential to exploit this system to decrease pain and inflammation. Although the clinical research remains in its infancy, recent systematic reviews have found that 25 of 30 randomized controlled trials have demonstrated a significant analgesic effect. The authors concluded that cannabinoids currently available for clinical use demonstrate a modest analgesic effect and are safe for the management of chronic pain. There is a critical need for more translational research so that the excellent work of Dr. Itai Bab and our basic science colleagues around the world can move forward in providing novel cannabinoid-based medicines. This should include more potent analgesics that are limited in side effects with several routes of delivery. Our patients deserve additional agents for pain control with a novel mechanism of action, and cannabinoids are the new frontier.
- 13 November 2015
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 27 (3) , 189-191
Cannabinoids in the management of chronic pain: a front line clinical perspective
Chronic pain is an escalating public health problem. Currently available treatments are inadequate to control chronic pain conditions, and there is a critical need for novel treatments. Over a half century of elegant preclinical research has identified the presence of a sophisticated endocannabinoid system that is part of our natural pain and immune defense network. Convergent work has supported the significant potential to exploit this system to decrease pain and inflammation. Although the clinical research remains in its infancy, recent systematic reviews have found that 25 of 30 randomized controlled trials have demonstrated a significant analgesic effect. The authors concluded that cannabinoids currently available for clinical use demonstrate a modest analgesic effect and are safe for the management of chronic pain. There is a critical need for more translational research so that the excellent work of Dr. Itai Bab and our basic science colleagues around the world can move forward in providing novel cannabinoid-based medicines. This should include more potent analgesics that are limited in side effects with several routes of delivery. Our patients deserve additional agents for pain control with a novel mechanism of action, and cannabinoids are the new frontier.